Drug Type miRNA |
Synonyms CWT 003, CWT-003 |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization Causeway Therapeutics Ltd.Startup |
Active Organization Causeway Therapeutics Ltd.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acute Coronary Syndrome | Preclinical | GB | Causeway Therapeutics Ltd.Startup | 27 Jul 2022 |
Refractory angina | Preclinical | GB | Causeway Therapeutics Ltd.Startup | 27 Jul 2022 |
Skin aging | Preclinical | GB | Causeway Therapeutics Ltd.Startup | 27 Jul 2022 |